Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Lanzhou Huanghe Pharmaceutical is a well-established pharmaceutical manufacturer based in Lanzhou, China, and is a key subsidiary of the Lanzhou Huanghe Enterprise Group. The company specializes in a diverse range of products, including Traditional Chinese Medicines (TCM), chemical generics, and nutritional supplements. It is most famous for its Huanghe brand Compound Liquorice Tablets, which hold a significant market share in the Chinese respiratory medicine sector. The company's manufacturing facilities are GMP-certified, producing various dosage forms such as tablets, capsules, and granules. Lanzhou Huanghe Pharmaceutical focuses on therapeutic areas including respiratory health, gastroenterology, and infectious diseases. With a strong regional presence in Northwest China, the company distributes its products through an extensive national network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Lanzhou Huanghe Pharmaceutical.